March 15 (Reuters) - Polyphor AG POLN.S :
* FY REVENUES INCREASED ON A LIKE-FOR LIKE BASIS BY CHF 6.3 MILLION FROM LAST REPORTING
PERIOD TO
CHF 6.5 MILLION
* FY RESEARCH AND DEVELOPMENT COSTS INCREASED BY 37% COMPARED TO LAST YEAR TO A TOTAL OF CHF
44.8
MILLION
* TOTAL CASH POSITION TO CHF 133.8 MILLION (CASH AND CASH EQUIVALENTS) AS OF DECEMBER 31,
2018
* FOR 2019 WILL FOCUS ON ADVANCING PIPELINE, WITH SPECIAL ATTENTION TO PHASE III TRIALS OF
MUREPAVADIN AND BALIXAFORTIDE
Source text for Eikon: ID:nEQ4Kj7TYa
Further company coverage: POLN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))